跳到正文
原文
Nature 综合主刊· Cassandra Willyard·· 18 天前AI 评分51

某胆固醇药物临床试验失败:原因与未来

This cholesterol drug promised to be a game-changer. Why did it flop in the clinic — and is there still hope?

AI 导读

一种降低脂蛋白(a)水平的药物在临床试验中未能显示心血管益处,科学家正在努力理解其失败原因及未来可能。

正文

Nature, Published online: 03 November 2026; doi:10.1038/d41586-026-03504-2

Physicians were excited about several therapies that slash levels of lipoprotein(a) — an important cardiovascular risk factor. One major trial failed to show a benefit, and now scientists are scrambling to work out what that means.

来源:Nature 综合主刊 · nature.com